X0306 4 2022-02-15 false 0001404123 1Life Healthcare Inc ONEM 0001800611 Diamond Andrew S C/O 1LIFE HEALTHCARE, INC. ONE EMBARCADERO CENTER, SUITE 1900 SAN FRANCISCO CA 94111 false true false false Chief Medical Officer Common Stock 2022-02-15 4 M false 1777.00 A 110751.00 D Common Stock 2022-10-24 4 M false 22251.00 12.16 A 133002.00 D Common Stock 2022-10-24 4 M false 45000.00 6.54 A 178002.00 D Common Stock 2022-10-24 4 M false 46875.00 4.36 A 224877.00 D Common Stock 2022-10-24 4 M false 70085.00 11.56 A 294962.00 D Common Stock 2022-10-24 4 S false 293185.00 17.0804 D 1777.00 D Restricted Stock Units 2022-02-15 4 M false 1777.00 0.00 D Common Stock 1777.00 5329.00 D Stock Options (Right to buy) 12.16 2022-10-24 4 M false 22251.00 0.00 D 2032-01-14 Common Stock 22251.00 96420.00 D Stock Option (Right to Buy) 6.54 2022-10-24 4 M false 45000.00 0.00 D 2026-11-16 Common Stock 45000.00 0.00 D Stock Option (Right to Buy) 4.36 2022-10-24 4 M false 46875.00 0.00 D 2028-02-14 Common Stock 46875.00 0.00 D Stock Option (Right to Buy) 11.56 2022-10-24 4 M false 70085.00 0.00 D 2026-11-20 Common Stock 70085.00 26032.00 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of the issuer's common stock. RSUs convert into the issuer's common stock on a one-for-one basis. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan and were conducted by the reporting person for tax and estate planning purposes. The reporting person has adopted Rule 10b5-1 plans in the past and has adopted this Rule 10b5-1 plan in the ordinary course. The trading plans and their parameters do not reflect the reporting person's views on the closing of the pending, previously announced, merger or the prospects of the Company's business after the closing. This transaction was executed in multiple trades at prices ranging from $17.06 to $17.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. On 1/15/2021, the reporting person was granted 7,106 restricted stock units vesting in equal annual installments over four years on the anniversary of the vesting commencement date, subject to the reporting person's continuous service as of each such date. The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years commencing on the vesting commencement date, subject to the reporting person's continuous service as of each such date. /s/ Ivy Tseng, Attorney-in-Fact for Andrew Diamond 2022-10-25